Helix BioMedix, Inc. (HXBM)
USD 7.18
(0.0%)
USD 7.18
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.02 Million USD | -23.03% |
| 2022 | 3.93 Million USD | 0.0% |
| 2011 | 2.97 Million USD | -43.11% |
| 2010 | 5.22 Million USD | 159.75% |
| 2009 | 2.01 Million USD | -25.55% |
| 2008 | 2.7 Million USD | 33.71% |
| 2007 | 2.02 Million USD | -33.79% |
| 2006 | 3.05 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 3.02 Million USD | -23.03% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -130856.104% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -54.484% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 71.337% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -447.904% |
| Rebus Holdings, Inc. | 5000.00 USD | -60401.72% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 97.677% |
| Qrons Inc. | 420.00 USD | -720158.571% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -292.54% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 89.174% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -529.496% |
| Skye Bioscience, Inc. | 11.94 Million USD | 74.665% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 92.213% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 58.1% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -3861.922% |
| SQZ Biotechnologies Company | 107.18 Million USD | 97.178% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -111.244% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -4080.316% |
| Mesoblast Limited | 667.9 Million USD | 99.547% |
| Marizyme, Inc. | 22.01 Million USD | 86.259% |
| Genus plc | 1.02 Billion USD | 99.706% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -122.702% |
| Pharming Group N.V. | 462.85 Million USD | 99.346% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 8.691% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -506.182% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -382.47% |
| ContraFect Corporation | 20.67 Million USD | 85.371% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -674.936% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -691.541% |
| IMV Inc. | 31.33 Million USD | 90.346% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 27.036% |
| MultiCell Technologies, Inc. | 126.22 USD | -2396577.23% |
| ONE Bio Corp. | 70.08 Million USD | 95.684% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -221.924% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 97.646% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -600.715% |
| Q BioMed Inc. | 3.51 Million USD | 13.95% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 91.401% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -1057.808% |
| Biomind Labs Inc. | 73.81 Thousand USD | -3997.977% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.322% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -108.793% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 89.921% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -10.15% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -340.021% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -16.207% |
| GB Sciences, Inc. | 103.44 Thousand USD | -2824.427% |
| Alpha Cognition Inc. | 2.45 Million USD | -23.364% |
| HST Global, Inc. | 1526.00 USD | -198136.304% |
| CSL Limited | 38.02 Billion USD | 99.992% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -206.193% |
| Halberd Corporation | 10.13 Thousand USD | -29759.698% |
| Enzolytics Inc. | 361.7 Million USD | 99.164% |
| Agentix Corp. | 261.39 Thousand USD | -1057.299% |
| Resverlogix Corp. | 8.11 Million USD | 62.722% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -61.09% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.933% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 93.658% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -372.924% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -13178.987% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 66.197% |
| AVAX Technologies, Inc. | 7.37 Million USD | 58.994% |
| Zenith Capital Corp. | 7410.00 USD | -40724.372% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.911% |
| Ember Therapeutics, Inc. | 184.00 USD | -1643968.478% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -840.034% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -1057.423% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -225.993% |
| Kadimastem Ltd | 2.3 Million USD | -31.293% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 94.26% |
| BioStem Technologies, Inc. | 14.56 Million USD | 79.224% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -5198.431% |
| LadRx Corporation | 2.3 Million USD | -31.076% |
| Cell Source, Inc. | 195.17 Thousand USD | -1449.967% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -755.47% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -755.47% |
| NovAccess Global Inc. | 62.24 Thousand USD | -4759.732% |
| Affymax, Inc. | 7.44 Million USD | 59.357% |
| Itoco Inc. | 1.4 Million USD | -116.066% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -3062.43% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -2753.855% |
| Mobile Lads Corp. | 52.00 USD | -5817373.077% |
| CytoDyn Inc. | 11.13 Million USD | 72.835% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -2015.859% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -16818.826% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -684.777% |
| SYBLEU INC | 330.46 Thousand USD | -815.395% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -638.867% |
| International Stem Cell Corporation | 5.39 Million USD | 43.876% |
| Bioxytran, Inc. | 137.63 Thousand USD | -2097.857% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 79.835% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 81.754% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -3729.223% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -249.852% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 59.757% |
| Neutra Corp. | 2851.00 USD | -106006.138% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 90.665% |
| PureTech Health plc | 693.97 Million USD | 99.564% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 62.519% |
| IXICO plc | 15.84 Million USD | 80.907% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 63.474% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 97.072% |
| CSL Limited | 38.02 Billion USD | 99.992% |
| Cellectis S.A. | 333.99 Million USD | 99.094% |